RAFOXANIDE/PROVET 300MG/TAB ΔΙΣΚΙΟ
RAFOXANIDE/PROVET 300MG/TAB ΔΙΣΚΙΟ
Authorised
- Rafoxanide
Product identification
Medicine name:
RAFOXANIDE/PROVET 300MG/TAB ΔΙΣΚΙΟ
Active substance:
- Rafoxanide
Target species:
-
Sheep
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rafoxanide300.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Sheep
-
Meat and offal42dayΓΑΛΑ: Δεν επιτρέπεται η χρήση σε θηλθκά πρόβατα που παράγουν γάλα για ανθρώπινη κατανάλωση, περιλαμβανομένης της ξηράς περιόδου και να μην χρησιμοποιείται για ένα έτος πριν από τον πρώτο τοκετό
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AG05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- PROVET S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Provet S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 89517/15-12-2009/K-0041601
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
